Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Bermudez

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|July 23, 2014
Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivityJens Schmitz, Dorina van der Mey, Marcel Bermudez, et al.
British Journal of Pharmacology|February 24, 2025
A bio. tools collection of online resources for GPCR researchTõnis Laasfeld, Friederike Wunsch, Avgi E Apostolakou, et al.
The Journal of Biological Chemistry|June 15, 2016
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled ReceptorAndreas Bock, Marcel Bermudez, Fabian Krebs, et al.
Scientific Reports|March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor AgonistsMaria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
EMBO Molecular Medicine|June 14, 2024
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Nature Communications|May 21, 2024
Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Nature Communications|April 26, 2024
Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
ACS Pharmacology & Translational Science|October 19, 2020
Ligand-Specific Allosteric Coupling Controls G-Protein-Coupled Receptor SignalingJanine Holze, Marcel Bermudez, Eva Marie Pfeil, et al.
British Journal of Pharmacology|February 2, 2022
Community guidelines for GPCR ligand bias: IUPHAR review 32Peter Kolb, Terry Kenakin, Stephen P H Alexander, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|July 23, 2014
Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivityJens Schmitz, Dorina van der Mey, Marcel Bermudez, et al.
British Journal of Pharmacology|February 24, 2025
A bio. tools collection of online resources for GPCR researchTõnis Laasfeld, Friederike Wunsch, Avgi E Apostolakou, et al.
The Journal of Biological Chemistry|June 15, 2016
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled ReceptorAndreas Bock, Marcel Bermudez, Fabian Krebs, et al.
Scientific Reports|March 30, 2020
N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor AgonistsMaria Dumitrascuta, Marcel Bermudez, Tanila Ben Haddou, et al.
EMBO Molecular Medicine|June 14, 2024
Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Nature Communications|May 21, 2024
Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
EMBO Molecular Medicine|November 7, 2024
Author Correction: Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseasesPartho Protim Adhikary, Temilolu Idowu, Zheng Tan, et al.
Nature Communications|April 26, 2024
Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxinsUmer Bin Abdul Aziz, Ali Saoud, Marcel Bermudez, et al.
ACS Pharmacology & Translational Science|October 19, 2020
Ligand-Specific Allosteric Coupling Controls G-Protein-Coupled Receptor SignalingJanine Holze, Marcel Bermudez, Eva Marie Pfeil, et al.
British Journal of Pharmacology|February 2, 2022
Community guidelines for GPCR ligand bias: IUPHAR review 32Peter Kolb, Terry Kenakin, Stephen P H Alexander, et al.
Pageof 6